CXCR3 and colorectal carcinoma: A contradictory study examined expression of CXCR3/4 in 25 CRC-I, 93 CRC-IIA and 27 CRC-IIB patients using IHC found no significant correlation between high expression of CXCR3/4 and 5-year DFS or clinicopathological features using IHC in CRC-II (p(IIA) = 0.592, p(IIB) = 0.573) [61].